Projecting the Benefit of Vericiguat in Populations Simulated From Paradigm-hf and Dapa-hf: Insights From the Victoria Trial
Year: 2024
Type: article
Institution: Duke Clinical Research Institute
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4393996371
